Director/PDMR Shareholding
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY DIRECTORS AND PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Vesting of Share Awards
Awards over ordinary shares of the Company under the Deferred Share Plan have become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustee of the Savills US Employee Benefit Trust effected the transfer of shares to a PDMR of the Company based in North America on 19 June 2026 as follows:-
PDMR
Number of Shares Transferred
Shareholding following this notification
Shareholding as a % of issued share capital
David Lipson
37,974
213,734
0.15%
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.
1.
Details of the Director/ PDMR
(a)
Name
David Lipson
2.
Reason for the notification
(a)
Position/ status
Chief Executive Officer - Savills North America/ PDMR
(b)
Initial notification/ Amendment
Initial notification
3.
Details of the issuer
(a)
Name
Savills plc
(b)
LEI
213800WXICGMBWHTA933
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the Financial Instrument
Savills plc Ordinary Shares of 2.5p each
(b)
Identification code of the Financial Instrument
GB00B135BJ46
(c)
Nature of the transaction
Vesting of awards under the Company's Deferred Share Plan
(d)
Price(s) and volume(s)
Price(s)
Volume(s)
£nil per share
37,974
(e)
Aggregated information
- Aggregated volume
- Price
N/A
(f)
Date of the transaction
19 June 2026
(g)
Place of the transaction
Outside a trading venue
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
19 June 2026
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHZZGMVFLVGVZM
